Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics

Scholarly Works

• Pang, N. Y.-L.; Pang, A. S.-R.; Pang, K. Y.-L.; Dinesh, T.; Wang, D.-Y.; Srinivasan, D. K. Advancing Otology through Nanoparticle-Based Interventions for Inner Ear Treatment. ACS Applied Nano Materials 2026. doi:10.1021/acsanm.6c01453
• Asad Pour, O.; Opazo, F.; Rostamzadeh, J.; Ghanam, J.; Chetty, V. K.; Hila, A.; Neumann, U.; Hetze, S.; Barthel, L.; Best, J.; Schmidt, H. H.; Thakur, B. K. Combinational CSF1R/PD-L1 targeting by BM-MSC-derived exosome–liposome hybrid orchestrates tumor-associated macrophage phagocytosis in an in vitro tumor-microenvironment-dependent manner. Cancer Nanotechnology 2026, 17. doi:10.1186/s12645-026-00402-0
• Shadab, A.; Haider, M. F.; Abohassan, M. Lipid Nanoparticles Based Drug Delivery Systems: Design Innovations, Therapeutic Applications, and Translational Progress. Journal of Pharmaceutical Innovation 2026, 22. doi:10.1007/s12247-026-10876-5
• Rocchi, A.; Marchetti, L.; Decuzzi, P.; Teesalu, T.; Celia, C. Controlling nanoparticle targeting: from physicochemical design to molecular recognition. Nanomedicine (London, England) 2026, 1–17. doi:10.1080/17435889.2026.2688999
• Nayak, P.; Swain, S. K.; Jogamaya Das, I.; Samal, H. B. Next-generation antibody-drug conjugated nanoparticles in metastatic breast cancer: Mechanism, clinical advances, and translational opportunities. Next Nanotechnology 2026, 10, 100558. doi:10.1016/j.nxnano.2026.100558
• Cui, S.; Ye, Z.; Arral, M. L.; Liu, L.; Weng, B.; Zhang, X.; Nair, R.; Zhao, Y.; Sahoo, J. K.; Gao, S.; Wang, Y.; Qu, Z.; Shi, Z.; Xu, Q.; Kaplan, D. L. Silk-Based Protein Corona Enhances mRNA-LNP Vaccine Efficacy and Prevents Tumor Relapse. Advanced materials (Deerfield Beach, Fla.) 2026, 38, e21487. doi:10.1002/adma.202521487
• Nikhar, S.; Jahan, A.; Mahato, T.; Giri, A. S. Peptide and Antibody Functionalized Nanoparticles: Active Targeting Strategies for Next-Generation Contrast Agents and Drug Delivery Systems. ACS Applied Nano Materials 2026, 9, 10448–10477. doi:10.1021/acsanm.5c05449
• Dolatyari, M.; Rostami, A.; Yadav, A. Doped semiconductor quantum dots: From controlled synthesis and optical engineering to bioimaging and theranostic applications. Materials Today Chemistry 2026, 54, 103653. doi:10.1016/j.mtchem.2026.103653
• Alam, M. A. Emerging smart nanocarrier based drug delivery systems for cancer therapeutics. Next Nanotechnology 2026, 9, 100387. doi:10.1016/j.nxnano.2026.100387
• Srivastava, A.; Ahmad, A.; Siddiqui, S.; Islam, A. Innovations in targeted drug delivery: From nanotechnology to clinical applications. Next Nanotechnology 2026, 9, 100336. doi:10.1016/j.nxnano.2025.100336
• Zhao, Y.; Nie, X.; Yan, H.; Ren, J.; Zhao, J.; Tong, L.; Zhao, L.; Zhang, G.; Liu, H. Nanoparticle Drug Delivery Systems: The Future Direction for the Treatment of Tumors. International journal of nanomedicine 2026, 21, 598126–34. doi:10.2147/ijn.s598126
• Kołodziejczyk, A. M.; Karwowski, B. T.; Grala, M. Gold Nanoparticle Complexes with PAMAM Dendrimers for In Vitro Cancer Cytotoxicity Assessment: Synthesis via Ascorbic Acid Reduction. Molecules (Basel, Switzerland) 2026, 31, 1844. doi:10.3390/molecules31111844
• Sen, S.; Das, C.; Biswas, G. Overview of the Fundamentals of the Synthesis of Nanoparticles and Characterization Techniques. Nanotechnology in Plant Sciences; Springer Nature Switzerland, 2026; pp 35–60. doi:10.1007/978-3-032-24518-2_2
• Khoramipour, M.; Chegeni, M. M.; Moradbeygi, F.; Najafi, F.; Kabarkouhi, Z.; Poodeh, S. H.; Larijani, S. F.; Ghaemi, A.; Jevinani, H. N.; Goodarzi, A.; Beram, F. M.; Moeinzadeh, A.; Moghaddam, N. A.; Farmani, A. R.; Bernkop-Schnürch, A. Gold nanoparticles as a versatile theranostic platform in oncology: A comprehensive point of view on synthesis, properties, functionalization, and clinical translation. Colloid and Interface Science Communications 2026, 72, 100880. doi:10.1016/j.colcom.2026.100880
• Um, K.; Hui, J. Z.; Tsourkas, A.; Shin, Y.; Ruppa, A.; Wong, L.; Chiang, J. Antibody Conjugation Strategies for Ultrasound Microbubbles: A Review of Bioconjugation Chemistry and Clinical Translation. Ultrasound in medicine & biology 2026, 52, 1250–1262. doi:10.1016/j.ultrasmedbio.2026.03.013
• Mathis, B. J.; Zaboronok, A.; Shi, Y.; Nagumo, Y.; Nishiyama, H.; Hiramatsu, Y. Nanoparticle Clearance and New Horizons in Engineered Drug Delivery. Pharmaceutics 2026, 18, 471. doi:10.3390/pharmaceutics18040471
• Fatima, M.; AlQahtani, F.; Kesharwani, P. Recent Advances in Surface-Engineered Polymeric Nanoparticles for Targeted Paclitaxel Delivery in Breast Cancer Therapy. AAPS PharmSciTech 2026, 27. doi:10.1208/s12249-026-03414-6
• Chauhan, D. S.; Prasad, R.; Dhanka, M.; Kaur, N.; Vithalani, H.; Liyanapathirana, K.; Hebbandi Nanjundappa, R.; Gao, H.; Umeshappa, C. S. Nanoparticles-based phototherapy systems: molecular mechanisms and clinical applications. Signal transduction and targeted therapy 2026, 11. doi:10.1038/s41392-025-02536-w
• Brysgel, T. V.; Hood, E. D.; Milosavljevic, A.; Marzolini, N.; Zamora, M. E.; Wu, J.; Shuvaev, V. V.; Shuvaeva, T.; Kegel, M.; Muscat-Rivera, J.; Weissman, D.; Melamed, J. R.; Myerson, J. W.; Brenner, J. S.; Muzykantov, V. R.; Nong, J. Decoupling Physisorption from Chemisorption in Clickable Lipid Nanoparticles. ACS nanoscience Au 2026, 6, 348–356. doi:10.1021/acsnanoscienceau.5c00170
• Fattahi, A. S.; Jafari, M.; Farahavar, G.; Haghighi, E.; Abolmaali, S. S.; Tamaddon, A. M. Antibody-nanoparticle conjugates for precision targeting of immunosuppressive tumor microenvironment. Critical reviews in oncology/hematology 2026, 221, 105219. doi:10.1016/j.critrevonc.2026.105219

Explore citations to this article at